Worth reading
56In focus
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
70000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as equity compensation stock options
Who receives how much
Up to 700 stock acquisition rights, with 100 shares per right, representing up to 70,000 common shares upon full exercise
Directors elected at the general meeting of shareholders held on 21 May 2026 who meet the eligibility criteria. The number of eligible directors and the number of rights allocated to each: 非開示
The lower thin line represents the existing number of shares to which these shares will be added.
The accounting fair value of the stock acquisition rights on the allocation date
Amount of funds to be raised
Total amount paid in: ¥0 (no payment is required upon issuance of the stock acquisition rights); estimated net proceeds: Not disclosed
Terms of the stock acquisition rights
Exercise price
¥1 per share. Amendment provisions: Not disclosed
Exercise period
From 21 July 2027 through 20 July 2042
Number of Stock Acquisition Rights
Total number issued: up to 700; unexercised balance: Not disclosed
Reason for acquisition without consideration
In the event of a material violation of laws or internal regulations, a sentence of imprisonment or more severe punishment, appointment to a competing company without authorization, the death of a successor to the rights, or an offer to relinquish all stock acquisition rights, provided that the Board of Directors resolves to acquire the rights
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Conditions for lifting transfer restrictions
Conditions for lifting the transfer prohibition: Not disclosed. The holder must be a director or corporate auditor when exercising the rights, although the rights may be exercised within 5 years from the date of retirement
Categories and Number of Persons Covered
Directors: directors elected at the general meeting of shareholders held on 21 May 2026 who meet the eligibility criteria. Number of eligible directors and number of shares allocated: Not disclosed
Intended allottee's holding policy
The holders of the stock acquisition rights and their successors may not transfer the stock acquisition rights or provide them as collateral
Basis for determining the amount to be paid
The issue price of the stock acquisition rights is their accounting fair value on the allocation date. Discount rate and premium rate: Not disclosed
Procedures under the Corporate Code of Conduct
Resolved at a meeting of the Board of Directors held on 21 May 2026. Acquisition of opinions from other independent third parties and procedures for confirming shareholder intent: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as equity compensation stock options |
| Number of shares to be issued or disposed of | Up to 700 stock acquisition rights, with 100 shares per right, representing up to 70,000 common shares upon full exercise |
| Issue price and disposal price | The accounting fair value of the stock acquisition rights on the allocation date |
| Amount of funds to be raised | Total amount paid in: ¥0 (no payment is required upon issuance of the stock acquisition rights); estimated net proceeds: Not disclosed |
| Intended allottee | Directors elected at the general meeting of shareholders held on 21 May 2026 who meet the eligibility criteria. The number of eligible directors and the number of rights allocated to each: Not disclosed |
| Intended allottee's holding policy | The holders of the stock acquisition rights and their successors may not transfer the stock acquisition rights or provide them as collateral |
| Basis for determining the amount to be paid | The issue price of the stock acquisition rights is their accounting fair value on the allocation date. Discount rate and premium rate: Not disclosed |
| Exercise price | ¥1 per share. Amendment provisions: Not disclosed |
| Exercise period | From 21 July 2027 through 20 July 2042 |
| Number of Stock Acquisition Rights | Total number issued: up to 700; unexercised balance: Not disclosed |
| Conditions for lifting transfer restrictions | Conditions for lifting the transfer prohibition: Not disclosed. The holder must be a director or corporate auditor when exercising the rights, although the rights may be exercised within 5 years from the date of retirement |
| Reason for acquisition without consideration | In the event of a material violation of laws or internal regulations, a sentence of imprisonment or more severe punishment, appointment to a competing company without authorization, the death of a successor to the rights, or an offer to relinquish all stock acquisition rights, provided that the Board of Directors resolves to acquire the rights |
| Categories and Number of Persons Covered | Directors: directors elected at the general meeting of shareholders held on 21 May 2026 who meet the eligibility criteria. Number of eligible directors and number of shares allocated: Not disclosed |
| Procedures under the Corporate Code of Conduct | Resolved at a meeting of the Board of Directors held on 21 May 2026. Acquisition of opinions from other independent third parties and procedures for confirming shareholder intent: Not disclosed |
Items this document does not state (14)
Total issue valueEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesTransfer restriction periodTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the link between compensation for full-time directors and the Company's performance and share value, and to heighten their motivation and morale to improve performance and increase corporate value over the medium to long term by sharing with shareholders not only the benefits of a rising share price but also the risk of a declining share price.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.